New blood thinner tested to make heart procedures safer
NCT ID NCT02505399
Summary
This study tested whether a newer blood-thinning drug (ticagrelor) works better than a standard one (clopidogrel) during a procedure to clear severely hardened heart arteries. Researchers enrolled 180 patients with stable heart disease to see if the newer drug reduces heart muscle damage after the procedure. The goal was to find a safer medication approach for this common but delicate heart operation.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ATHEROSCLEROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Clinique Pasteur
Toulouse, Haute-Garonne, 31000, France
-
Fédération de Cardiologie CHU TOULOUSE
Toulouse, Haute-Garonne, 31059, France
-
Hospices civils de Lyon
Lyon, 69000, France
-
University Hospital
Nîmes, 30000, France
Conditions
Explore the condition pages connected to this study.